Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes

NCT00184600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

708

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: insulin detemir
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S